8 August 2017 (Tuesday) - Digital Morphology

Finally (!!!)  I got the report on the latest NEQAS digital morphology exercise (1703DM which I did on 28 June). I spotted the salient features… I thought it was a myeloproliferative/myelofibrosis case; it was actually a rather obscure form of ALML, but as the report said “It is not always possible to make a definite diagnosis on morphology alone”

I spotted the salient features… I think I did good.

8 August 2017 (Tuesday) - Transfusion News email

The Transfusion News email arrived in my in-box this morning. I was rather intrigued by the articles on massive transfusions and trauma, but I wasn’t entirely sure about the ADAMS antibody/antigen stuff.

Low ADAMTS13 antigen and high ADAMTS13 antibody levels associated with mortality in TTP patients

August 1, 2017
While thrombotic thrombocytopenic purpura (TTP) has a mortality rate of approximately 10% even when treated, predictors of mortality are unknown. In a prospective cohort registry of 292 TTP patients with 312 episodes of TTP in the United Kingdom, factors associated with mortality were evaluated. TTP patients with high amounts (top quartile) of a disintegrin and [Read More]

Systematic Review Recommends Standard Ratios of Blood Products for Massive Transfusion

July 26, 2017
Observational studies have suggested that higher ratios of plasma and platelets to red blood cells (RBCs) might lead to better outcomes for severely bleeding patients requiring massive transfusions. Researchers recently performed a systematic review of the literature in order to determine if a 1:1:1 ratio of plasma, platelets and RBCs decreased morbidity and mortality compared [Read More]

Group A Plasma in Trauma with Nancy Dunbar & Tait Stevens

August 5, 2017 | BBGuy Podcast
Transfusion News has joined forces with Blood Bank Guy to bring you the best possible Transfusion Medicine educational content and current news.

8 August 2017 (Tuesday) - Transplantation Newsletter

The Wiley transplantation newsletter appeared in my in-box today. For all that I am very grateful to the nice people at Wiley, I wonder if I need to reconsider my sources of C.P.D. So much of the stuff I receive is of a clinical bent…